<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main"></title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">0D957EEEB4CD331CC20B2D1358FA73D2</idno>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2" ident="GROBID" when="2023-03-30T18:12+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Inclusion body myositis</head><p>Since the early description of cases of inflammatory myopathy with unusual filamentous inclusions in muscle fibres'-3 inclusion body myositis has come to be recognised as a major form of idiopathic inflammatory myopathy with distinctive clinical and pathological features which accounts for up to a third of patients with inflammatory myopathy seen in a neuromuscular clinic. The condition, which predominates in males, is characterised by the insidious development of muscular weakness and atrophy which is curiously selective, involving particularly the quadriceps femoris muscles in the lower limbs and the forearm muscles, particularly the finger flexors, and especially the flexor digitorum profundus in the upper limbs.4 Cutaneous and other systemic manifestations are usually absent although occasional patients have an associated connective tissue disorder, autoimmune disease, or immunodeficiency state.56 Asymmetry of muscle involve- ment is not uncommon and may be prominent in some cases, thereby compounding the diagnostic difficulty. With progression, which is usually protracted over a period of years, the weakness becomes more widespread and the selectivity of muscle involvement less apparent.7 Dysphagia occurs in 20-30% of patients and is sometimes severe, requiring a cricothyroid myotomy or gastrostomy.8 Although most cases are sporadic, familial forms with a variable phenotype and either autosomal dominant or recessive inheritance also occur.</p><p>Affected people often present late in the course of the disease, when falls begin to occur because of quadriceps weakness and rarely respond to corticosteroid or immuno- suppressive therapy.5 9 The diagnosis is often delayed because of lack of familiarity with the condition, an atypical pattern of muscle involvement, the fact that the serum cre- atine kinase concentration may be normal or only mildly increased, and the sometimes confusing finding of a mixed neuromyopathic pattern on electromyography. Some patients are initially misdiagnosed as having motor neuron disease. Confirmation of the diagnosis of inclusion body myositis requires a muscle biopsy, preferably an open biopsy from a muscle which is not too severely affected, and recognition of the characteristic rimmed vacuoles and hyaline eosinophilic inclusions in cryostat sections and intranuclear or cytoplasmic aggregates of 15-18 nm tubulofilamentous structures in muscle fibres by electron microscopy.5 'Â°" T Cells, particularly those of the CD8+ phenotype, predominate in the inflammatory infiltrates and may invade non-necrotic muscle fibres together with</p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><p>macrophages."2 However, the extent of inflammatory infil- tration is variable, sometimes being inconspicuous or even absent, especially in familial cases.</p><p>There have always been unresolved questions about this rather mysterious condition. Foremost among these is the significance of the muscle fibre inclusions and their rela- tion to what seems to be an autoaggressive T cell reaction occurring in the context of class I MHC expression by muscle fibres." Chou2 first suggested that the intranuclear and cytoplasmic tubulofilamentous inclusions resembled myxovirus nucleocapsids and, on the basis of immunocytochemical findings, subsequently proposed that a defec- tive mumps virus was the causative agent."3 This now seems unlikely, as further studies using in situ hybridisation"4 and the sensitive polymerase chain reaction'5 have failed to confirm the presence of myxovirus genomic material in muscle tissue. Of uncertain relevance also are the findings in some cases of inclusion body myositis of mitochondrial abnormalities and mtDNA deletions. <ref type="bibr">'6</ref> In 1991 Mendell et all' first reported the finding of amyloid deposits in association with the autophagic vac- uoles in muscle fibres in inclusion body myositis. Recent immunohistochemical studies have shown the presence of ,B amyloid, ubiquitin, and an array of other proteins in the vacuoles. <ref type="bibr">'8-21</ref> These include the prion protein, apolipopro- tein E, and hyperphosphorylated tau, which are also present in the cerebral plaques of Alzheimer's disease. In addition, the nicotinic acetylcholine receptor and fibro- blast growth factor and its receptor have been localised ultrastructurally to the tubulofilaments which resemble the paired helical filaments that accumulate in nerve cells in Alzheimer's disease. These findings have led to the intriguing suggestion that the degenerative process in the muscle fibres in inclusion body myositis has something in common with that in the brain in Alzheimer's disease.</p><p>The exact relation between the mononuclear infiltrates and the inclusion bodies in inclusion body myositis remains unclear. Several possibilities exist.</p><p>(1) Autoimmunity to muscle components Inclusion body myositis is usually considered to be an autoimmune muscle disease and the T cells which are pre- sent in the endomysial infiltrates are believed to be directed at antigens expressed by skeletal muscle cells.5 No target antigen has been identified but if a true autoim- mune response is involved at least two scenarios are possible: (a) an autoimmune attack may cause muscle damage which in turn stimulates formation of inclusion bodies in response to this damage, or (b) the immune response may be directed at one or more of the protein components of the inclusions as a consequence of their excessive produc- tion and accumulation. Several histological and immunocytochemical features support the autoimmune hypothesis. These include the apparent invasion of non- necrotic muscle fibres by CD8+ T cells in biopsies,22 the expression of MHC class 123 and intercellular adhesion molecule-1 (JCAM-1)24 by non-necrotic muscle fibres which are invaded by the infiltrating T cells, the associa- tion of inclusion body myositis with other autoimmune diseases,25 and the strong HLA association with this dis- ease (see below). Some information has also been gained regarding the properties of the infiltrating T cells. A pro- portion express the enzymes granzyme and perforin,26 which are thought to play a major part in cell mediated cytotoxic responses,27 and those associated with muscle fibre infiltration showed raised levels of expression of ICAM-1 and lymphocyte function associated antigen-I (LFA-1) and a moderate increase in LFA-3 expression.24 These adhesion molecules play a part in T cell activa- tion.28 Endomysial T cells were predominantly CD45RO+, indicative of memory rather than naive T cells.29 Raised expression of the adhesion molecules on lymphoid and muscle cells was, however, also demonstrable in patients with Duchenne muscular dystrophy.24</p><p>There is, however, very little direct in vitro evidence which shows an antigen specific myocytotoxic effect of T cells derived from patients with inclusion body myositis. The one published report, which investigated reactivity of T cell lines derived from patients with inclusion body myositis to autologous muscle cells, showed borderline cytotoxicity by cells from only one patient.3' Granzyme and perforin are likely to be expressed by cytotoxic cells which are activated non-specifically,27 as are ICAM-1, LFA-1, and LFA-3. The presence of CD8+ cells of the memory phenotype in the muscle lesions may simply reflect the fact that T cells with a memory phenotype are more likely to traffic through non-lymphoid tissues and can more readily cross the endothelium to enter inflamed or damaged tissues.3' Analysis of TCR V gene usage in mus- cle biopsies has not provided evidence to support an anti- gen specific immune response to muscle in inclusion body myositis. This has been examined by at least two groups using either the polymerase chain reaction or immunohis- tochemical analysis.32 In each study V,B3 positive T cells were commonly found but there was no evidence of mon- oclonality. It was suggested that the predominance of V,3 and Voa2 bearing T cells may have resulted from the influ- ence of a local superantigen. <ref type="bibr" target="#b32">32</ref> Thus although some circumstantial evidence suggests that inclusion body myositis is an autoimmune disease this is far from proved.</p><p>(2) Inclusion body formation as a stimulus for muscle damage The formation of intracellular inclusion bodies may be the primary event in inclusion body myositis. This may cause damage to muscle fibres and the inflammatory infiltrate may then occur as a consequence of this damage. Some evidence supports a distinction between the formation of the inclusions and the inflammatory response. In heredi- tary inclusion body myositis inclusion bodies containing the characteristic proteins can be shown but the inflammatory infiltrate is minimal."3 Primary muscle cultures prepared from patients with hereditary inclusion body myopathy have been shown to develop inclusions in cul- ture in the absence of inflammatory cells and the forma- tion of these inclusions is enhanced when these muscles are innervated in vitro. <ref type="bibr" target="#b34">34</ref> The overexpression of amyloid precursor protein (APP) in normal muscle cells after gene transduction in tissue culture has recently been shown to produce myotube vacuolation and degeneration along with deposition of congo red positive material and the appearance of nuclear inclusions and tubulofilaments (Askanas et al, unpublished data). Furthermore, treatment of patients with inclusion body myositis with steroids has been shown to reduce the inflammatory component in muscle despite continued disease progression and forma- tion of inclusions. <ref type="bibr" target="#b33">33</ref> The demonstration of increased levels of mRNA encod- ing APP, prion protein, and nicotinic acetylcholine recep- tor3-36 are consistent with the excessive endogenous production of inclusion body proteins. Synthesis of several of these proteins is also increased in regenerating muscle cells.34 Thus whether the overproduction of these proteins is a primary cause of muscle damage or is a response within damaged muscle is unclear. The overexpression of certain fragments of APP has been shown to be toxic to the expressing cells37 and accumulation of ,BA4 has been reported to be neurotoxic, toxicity probably being dependent on the formation of /B pleated sheets.38 Various mutant forms of APP which have been linked with Alzheimer's disease have been reported to confer overpro- duction of fBA4 by cells expressing these genes.38 It has been speculated that abnormal accumulation of one or a few of these proteins in inclusion body myositis results in accumulation of the others34 and the ultimate formation of inclusions.</p><p>A high proportion of the proteins found in the inclusions is associated with the normal neuromuscular junction. <ref type="bibr" target="#b34">34</ref> An alternative hypothesis to explain their accumulation is the loss of control of expression of these genes via a "master-switch" gene product which may have particular relevance to proteins normally expressed at the neuromuscular junction. <ref type="bibr" target="#b34">34</ref> The net effect could be direct muscle fibre damage due to abnormal protein accumula- tion, an autoimmune response to one or more of these proteins, or both.</p><p>(3) Muscle fibre damage exacerbated by T cell infiltrates T Cells have been shown to infiltrate skeletal muscle in situations in which muscle degeneration and regeneration is occurring without any autoimmune basis. Such situations include Duchenne muscular dystrophy'2 and exercise induced muscle damage.3940 Further, in vitro studies have shown that T lymphocytes can adhere to autologous and allogeneic myotubes and myoblasts in culture.3'4' This adherence is increased when myoblasts, in particular, are exposed to cytokines which upregulate the expression of adhesion molecules such as ICAM-1 and when the T cells are activated.4' This kind of environment presumably exists in damaged skeletal muscle; myoblasts are activated to proliferate, inflammatory cells may release a variety of cytokines, and muscle degeneration and regeneration are occurring. Human myoblasts can secrete IL-642 and per- haps other chemotactic factors which may contribute to the inflammatory process. In vitro studies also suggest that under certain conditions lymphocytes can form intimate membrane-membrane interactions with muscle cells by what is presumably an antigen/TCR-independent mecha- nism and as a result of this interaction certain enzymes can be delivered directly into muscle cells. 43 The in vivo significance of this phenomenon is not known but it does indicate that lymphocytes can make intimate effective contact with muscle cells in situations other than an antigen-specific immune response.</p><p>The properties of T cells which accumulate in other pathological conditions such as tumours or atherosclerotic plaques may be relevant.44 45 Although having no apparent antigen specific function many of these T cells are capable of secreting basic fibroblast growth factor (BFGF) and a heparin binding epidermal growth factor-like growth fac- tor. Both of these molecules are potent mitogens for various cell types45 and BFGF, at least, has been shown to play an important part in muscle regeneration.4647 Indeed, in regenerating murine muscle BFGF has been demon- strated in mononuclear cells, although a distinction between lymphocytes and macrophage/monocytes was not made.47 Taken together these data suggest that T cells can interact with muscle cells by means other than TCR anti- gen interaction and that the T cells are capable of deliver- ing products which might cause muscle damage and influence the expression of the proteins found in the inclu- sion bodies. The molecular signals which attract the T cells to muscle cells in these situations are unknown, as are the molecules which facilitate the membrane-mem- brane interactions, although adhesion molecules such as ICAM-1 are likely to be involved. Recent observations regarding the interaction of T cells with muscle fibres in polymyositis48 may also have some relevance to inclusion body myositis. The points of membrane interaction of T cells with the invaded muscle fibres were shown to stain most intensely for APP (T cell) and NCAM-1 (muscle fibres) suggesting a possible interaction between these molecules during muscle fibre invasion.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Genetic factors in inclusion body myositis</head><p>An analysis of genetic associations with inclusion body myositis may provide clues to the aetiology of this disease. The most obvious candidate genes are those which have been associated with other autoimmune diseases and those encoding the proteins which are found associated with the intramuscular inclusions. The most common markers which have been analysed in autoimmune dis- eases are those within the major histocompatibility com- plex (MHC) encoded on chromosome 6. This gene complex encodes the class I and class II HIA antigens which are responsible for the presentation of antigenic peptides to T lymphocytes.4950 Also included in this com- plex are some of the genes encoding components of the complement system-namely, C4A, C4B, C2, and factor B. <ref type="bibr" target="#b50">50</ref> We have recently shown that over 90% (14/15) of our patients with inclusion body myositis possess the DR3 allele.5' Further, in most of these patients the DR3 is present on a haplotype which is marked by HILA B8 and has a deletion encompassing the C4A locus.52 In the remainder DR3 is present on a haplotype marked by HLA B18, BfF1, and a deletion of C4B.53 Both of these extended haplotypes have been associated with other autoimmune diseases such as myasthenia gravis, autoimmune thyroid disease, systemic lupus erythematosus (B8/DR3), and insulin dependent diabetes mellitus (B 1 8/DR3) . Recent reports that some patients with inclusion body myositis also present with common variable immunodefi- ciency656 are consistent with this finding as the B8/DR3 haplotype has also been associated with this condition.57 58   The very strong association with DR3 and its presence on two different extended haploptypes suggest a primary role for this allele in the predisposition to inclusion body myositis. Because most T cells seen in inclusion body myositis muscle are CD8+ any direct role for DR3 may be at the phase of CD4+ helper T cell sensitisation.</p><p>On the other hand the very high frequency of aberra- tions in the C4 region (over 90% of patients had at least one C4 gene deleted) raises the possibility that partial deficiency in complement activity may play some part in the pathogenesis of the disease. An increased frequency of C4 null alleles has been described in SLE and a role in the pathogenesis of that disease, by virtue of an effect on immune complex clearance, has been suggested.55 A role in inclusion body myositis is less readily explained. Apart from the classic MHC and complement genes several other genes are encoded within the MHC. It has become clear that the DR3 bearing haplotypes associated with inclusion body myositis are extremely stable so that alleles of the genes which form part of these haplotypes (for instance, between B8 and DR3) are likely to be identical in unrelated people bearing them.52 59 Thus a role for a linked gene, the function of which has yet to be deter- mined, cannot be excluded. One such gene which has recently been described and which is preferentially, although not excusively, expressed in skeletal muscle60 may be worthy of investigation.</p><p>Genetic variants of the genes encoding the APP and prion protein, prominent components of the rimmed vac- uoles of inclusion body myositis, have been associated with deposition of these proteins in diseases affecting the CNS. Mutations in or near the ,BA4 encoding region of the APP gene have been associated with Alzheimer's dis- ease and Dutch type hereditary cerebral haemorrhage and excessive production of the ,3A4 protein. <ref type="bibr" target="#b38">38</ref> We have sequenced this region of the APP gene in our patients with sporadic inclusion body myositis and found no evidence for an abnormal sequence in inclusion body myositis; nor have mutations been found in familial inclusion body myositis.6' Certain mutations in the prion gene have also been associated with the deposition of this protein in Gerstmann-Straussler-Scheinker syndrome and Creutzfeldt-Jakob disease, whereas homozygosity for either of the two common polymorphic variants at codon 129 of this gene has been associated with Creutzfeldt-Jakob disease.62 Sequencing of the entire protein coding region of the prion gene in our group of patients with inclusion body myositis showed no mutations and a nor- mal distribution of the codon 129 polymorphisms.</p><p>A polymorphic variant of the APOE gene (e4) has been strongly associated with Alzheimer's disease63 and in vitro experiments have shown that the e4 protein product has an increased binding affinity for ,BA4 but that its capacity to bind hyperphosphorylated tau is reduced64 65 compared with other alleles of APOE. It has been proposed that these properties influence both the deposition of ,BA4 and the rate of development of neurofibrillary tangles in Alzheimer's disease.65 The parallels between the inclusions of inclusion body myositis and the amyloid plaques of Alzheimer's disease-including the presence of APOE in the inclusions, as well as the association between Alzheimer's disease and APO E4-led us, and others, to examine the allelic frequencies of the APO 84 gene in inclusion body myositis.66 67 The frequency of APO e4 was statistically increased in our group of patients with inclu- sion body myositis compared with normal controls and patients with other forms of inflammatory muscle disease67 whereas in a second study no statistically significant increase in the frequency of this allele was demonstrable.66</p><p>These studies comprised small numbers of patients and this point will require clarification. In normal skeletal muscle APOE has been shown to be concentrated at the neuromuscular junction and may be up-regulated as a consequence of injury.34 68 The APO E4 protein may influ- ence the formation of the inclusions of inclusion body myositis by virtue of its increased binding to fA4 and its decreased affinity for the tau protein.6465 Apart from its role in lipid redistribution between and within tissues69 APOE may also play some part in muscle regeneration and has been shown to be capable of modulating antigen specific and non-specific T cell activation. <ref type="bibr" target="#b69">[69]</ref><ref type="bibr" target="#b70">[70]</ref><ref type="bibr" target="#b71">[71]</ref> The allelic variants may differ in their capacity to perform these functions and these differences in function may also contribute to the development of inclusion body myositis. It is clear, however, that an association with APOE e4 will not provide an explanation for the development of inclusion body myositis in all patients. Development of this disease is likely to be multifactorial. Various combinations of genetic factors, probably together with an appropriate environmental stimulus, may interact to precipitate the condition seen as inclusion body myositis. Summary Concepts of inclusion body myositis have changed considerably over the past decade. Of particular importance has been the discovery that amyloid and some other proteins, which are also found in the brain in Alzheimer's disease, are present in the vacuolar inclusions in inclusion body myositis and seem to accumulate as a result of their increased production in muscle fibres. The factors responsible for this increased production and accumulation remain to be determined. Although inclusion body myositis is usually considered to be an autoimmune disease of muscle, the evidence for this remains circumstantial and the relation between the T cell infiltrates and the abnor- mal protein accumulation in muscle fibres remains unclear. The variable extent of the inflammatory infiltrate in both sporadic and familial cases and the continued progression of the condition and of amyloid deposition despite corticosteroid and other immunosuppressive treat- ment in most cases suggest that the inflammatory process may be an epiphenomenon although it is possible that it may contribute to the muscle damage. Recent studies have shown that certain genetic factors may play a part in the pathogenesis, even in sporadic inclusion body myositis. These include certain HLA alleles (DR3) and complement haplotypes which could act by predisposing to the development of an immune response in muscle, and the APOe4 allotype which may favour the deposition of amyloid in muscle as has been postulated in Alzheimer's dis- ease. To date, no genetic variations have been found in the genes encoding the amyloid precursor protein or other proteins which accumulate in inclusion body myositis. A mutation in a "master switch" gene which controls the production of all of these proteins remains a theoretical possibility.</p><p>Productive areas of investigation in sporadic inclusion body myositis are likely to include detailed analyses of topics such as the control of APP expression and processing in skeletal muscle cells, the molecular response of skeletal muscle cells to injury, and the interaction between healthy and damaged muscle cells and T lymphocytes at the cellu- lar and molecular levels. Investigation of the genetic fac- tors determining each of the above as well as the very strong association with DR3 and the rapidly increasing range of genetic factors which are being shown to be rele- vant in Alzheimer's disease72 73 may provide important clues to the aetiology of this disease. Since ancient times people have believed garden heliotrope to be a cure for epilepsy and a host of other dis- orders, thus accounting for one of the plant's alternative names-all heal. In the 16th and 17th centuries, herbal- ists considered the herb a sedative for "nervous disorders" such as "hysteric complaints", an antispasmodic for con- vulsions, and a remedy for bad coughs and for constipa- tion. It has been said that the herb drives cats into a frenzy.</p><p>It is pictured on a commemorative stamp for the International Congress of Pharmacology, issued by Czechoslovakia in 1971 (Stanley Gibbons 1982, Scott 1775). </p></div>		</body>
		<back>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">Nedlands WA</title>
		<imprint>
			<biblScope unit="volume">6009</biblScope>
			<publisher>Australia Correspondence to: Professor FL Mastaglia</publisher>
		</imprint>
		<respStmt>
			<orgName>University Department ofMedicine and Australian Neuromuscular Research Institute, Queen Elizabeth II Medical Centre</orgName>
		</respStmt>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">A myopathy with cellular inclusions</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">D</forename><surname>Adams</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">J</forename><surname>Samaha</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">A</forename><surname>Kakulas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Transactions of the American Neurological Association</title>
		<imprint>
			<biblScope unit="volume">90</biblScope>
			<biblScope unit="page" from="213" to="216" />
			<date type="published" when="1965">1965</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Myxovirus-like structures in a case of human chronic polymyositis</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Chou</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">158</biblScope>
			<biblScope unit="page" from="1453" to="1455" />
			<date type="published" when="1967">1967</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Inclusion body myositis</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">J</forename><surname>Yunis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">J</forename><surname>Samaha</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lab Invest</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="240" to="248" />
			<date type="published" when="1971">1971</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Magnetic resonance imaging (MRI) of the forearm as a diagnostic aid in patients with inclusion body myositis (IBM)</title>
		<author>
			<persName><forename type="first">E</forename><surname>Sekul</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Chow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Dalakas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="page">A130</biblScope>
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Inclusion body myositis</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Chou</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Bailliere&apos;s Clinical Neurology</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page" from="557" to="577" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Common variable immunodeficiency and inclusion body myositis: a distinct myopathy mediated by natural killer cells</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Dalakas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Illa</forename><forename type="middle">I</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Neurol</title>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="page" from="806" to="810" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Inclusion body myositis</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">P</forename><surname>Lotz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">G</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Nishino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Stevens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">J</forename><surname>Litchy</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Brain</title>
		<imprint>
			<biblScope unit="volume">112</biblScope>
			<biblScope unit="page" from="727" to="747" />
			<date type="published" when="1989">1989</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Dysphagia in inclusion body myositis</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Wintzen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">T</forename><surname>Bots</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">M</forename><surname>De Bakker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Hulshof</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">W</forename><surname>Padberg</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J7 Neurol Neurosurg Psychiatry</title>
		<imprint>
			<biblScope unit="volume">51</biblScope>
			<biblScope unit="page" from="1542" to="1545" />
			<date type="published" when="1988">1988</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Treatment of inflammatory myopathies</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">L</forename><surname>Mastaglia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">A</forename><surname>Laing</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Zilko</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Bailliere&apos;s Clinical Neurology</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page" from="717" to="740" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Inflammatory myopathies</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">L</forename><surname>Mastaglia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">N</forename><surname>Walton</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Skeletal Muscle Pathology</title>
				<editor>
			<persName><forename type="first">F</forename><forename type="middle">L</forename><surname>Mastaglia</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">J</forename><forename type="middle">N</forename><surname>Walton</surname></persName>
		</editor>
		<meeting><address><addrLine>Edinburgh: Churchill-Livingstone</addrLine></address></meeting>
		<imprint>
			<date type="published" when="1992">1992</date>
			<biblScope unit="page" from="453" to="491" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Pathology of inflammatory myopathies. BaiUliere&apos;s</title>
		<author>
			<persName><forename type="first">G</forename><surname>Karpati</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Carpenter</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clinical Neurology</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page" from="527" to="556" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Monoclonal antibody analysis of mononuclear cells in myopathies. I: Quantitation of subsets according to diagnosis and site of accumulation and counts of muscle fibres invaded by T cells</title>
		<author>
			<persName><forename type="first">K</forename><surname>Arahata</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">G</forename><surname>Engel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Neurol</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page" from="193" to="208" />
			<date type="published" when="1984">1984</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Inclusion body myositis: a chronic persistent mumps myositis</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Chou</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hum Pathol</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="765" to="777" />
			<date type="published" when="1986">1986</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Inclusion body myosotis: the mumps virus hypothesis</title>
		<author>
			<persName><forename type="first">H</forename><surname>Nishino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">G</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">K</forename><surname>Rima</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Neurol</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="260" to="264" />
			<date type="published" when="1989">1989</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Inclusion body myositis: investigation of the mumps virus hypothesis by PCR</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Fox</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">K</forename><surname>Ward</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">D</forename><surname>Robbins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">L</forename><surname>Mastaglia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">R</forename><surname>Swanson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Muscle Nerve</title>
		<imprint>
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
	<note>in press</note>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Mitochondrial DNA deletions in inclusion body myositis</title>
		<author>
			<persName><forename type="first">A</forename><surname>Oldfors</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">G</forename><surname>Larsson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Lindberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Holme</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Brain</title>
		<imprint>
			<biblScope unit="volume">116</biblScope>
			<biblScope unit="page" from="325" to="336" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Amyloid filaments in inclusion body myositis: novel findings provide insight into nature of filaments</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Mendell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Sahenk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Gales</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Paul</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arch Neurol</title>
		<imprint>
			<biblScope unit="volume">48</biblScope>
			<biblScope unit="page" from="1229" to="1234" />
			<date type="published" when="1991">1991</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Light and electron microscopic localization of(amyloid protein in muscle biopsies of patients with inclusionbody myositis</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">AmJPathol</title>
		<imprint>
			<biblScope unit="volume">141</biblScope>
			<biblScope unit="page" from="31" to="36" />
			<date type="published" when="1992">1992</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Immunocytochemical localization of ubiquitin in inclusion body myositis allows its light-microscopic distinction from polymyositis</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Serdaroglu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="page" from="460" to="461" />
			<date type="published" when="1992">1992</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Muscle nicotinic acetylcholine receptor (nAChR) and its associated protein 43 Kd (43K) are highly accumulated in vacuolated muscle fibers (VMFs) of inclusion body myositis (IBM)</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bilak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">C</forename><surname>Froehner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="page">A131</biblScope>
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Immunocytochemical localization of apoliprotein E (ApoE) in inclusion body myositis (IBM)</title>
		<author>
			<persName><forename type="first">M</forename><surname>Mirabella</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">H</forename><surname>Weisgraber</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="page">A347</biblScope>
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Mononuclear cells in myopathies: quantitation of functionally distinct subsets, recognition of antigen-specific cell-mediated cytotoxicity in some diseases, and implications for the pathogenesis of the different inflammatory myopathies</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">G</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Arahata</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hum Pathol</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="704" to="721" />
			<date type="published" when="1986">1986</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Major histocompatibility complex class I antigen expression, immunolocalisation of interferon subtypes, and T-cell mediated cytotoxicity in myopathies</title>
		<author>
			<persName><forename type="first">A</forename><surname>Emslie-Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Arahata</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">G</forename><surname>Engel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hum Pathol</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page" from="224" to="231" />
			<date type="published" when="1989">1989</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Expression of cell adhesion molecules in inflammatory myopathies and Duchenne dystrophy</title>
		<author>
			<persName><forename type="first">De</forename><surname>Bleeker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">G</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J7 Neuropathol Exp Neurol</title>
		<imprint>
			<biblScope unit="volume">53</biblScope>
			<biblScope unit="page" from="369" to="376" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Inclusion body myositis: new concepts</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Sekul</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Dalakas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Seminars Neurol</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page" from="256" to="263" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Immunohistochemical analysis of perforin and granzyme A in inflammatory myopathies</title>
		<author>
			<persName><forename type="first">S</forename><surname>Orimo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Koga</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Goto</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neuromuscul Disord</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page" from="219" to="226" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">The binding and lysis of target cells by cytotoxic lymphocytes: molecular and cellular aspects</title>
		<author>
			<persName><forename type="first">G</forename><surname>Berke</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Annu Rev Immunol</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page" from="735" to="773" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Molecules involved in T cell co-stimulation</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">K</forename><surname>Jenkins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">G</forename><surname>Johnson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr Opin Immunol</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page" from="361" to="367" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Immunocytochemical study of CD45 T cell isoforms in inflammatory myopathies</title>
		<author>
			<persName><forename type="first">De</forename><surname>Bleecker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">G</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">AmJIPathol</title>
		<imprint>
			<biblScope unit="volume">146</biblScope>
			<biblScope unit="page" from="1178" to="1187" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Coculture with autologous myotubes of cytotoxic T cells isolated from muscle in inflammatory myopathies</title>
		<author>
			<persName><forename type="first">R</forename><surname>Hohlfeld</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">G</forename><surname>Engel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Neurol</title>
		<imprint>
			<biblScope unit="volume">199</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="498" to="507" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Homing of naive, memory and effector lymphocytes</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">R</forename><surname>Mackay</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr Opin Immunol</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page" from="423" to="427" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">The alpha beta T-cell receptor repertoire in inclusion body myositis: diverse pattems of gene expression by muscle-infiltrating lymphocytes</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">P</forename><surname>O'hanlon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Dalakas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">H</forename><surname>Plotz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">W</forename><surname>Miller</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Jf Autoimmunity</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page" from="321" to="333" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Restricted use of T cell receptor V genes in endomysial infiltrates of patients with inflammatory myopathies</title>
		<author>
			<persName><forename type="first">C</forename><surname>Lindberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Oldfors</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Tarkowski</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">EurJ Immunol</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page" from="2659" to="2663" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Idiopathic inflammatory myopathies: inclusion-body myositis, polymyositis and dermatomyositis</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mirabella</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr Opin Neurol Neurosurg</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page" from="448" to="456" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Inclusion body myositis: explanation for poor response to immunosuppressive therapy</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Barohn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Amato</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Sahenk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">T</forename><surname>Kissel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Mendell</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">45</biblScope>
			<biblScope unit="page" from="1302" to="1304" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Inclusion body myositis-recent advances</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Muscle Nerve</title>
		<imprint>
			<biblScope unit="page">S50</biblScope>
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
	<note>suppl 1</note>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Cytotoxicity mediated by conditional expression of a carboxyl-terminal derivative of the beta-amyloid precursor protein</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">L</forename><surname>Sopher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Fukuchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Smith</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Brain Res</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="207" to="217" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Molecular pathogenesis of f-amyloidosis in Alzheimer&apos;s diseaseand other cerebral amyloidoses</title>
		<author>
			<persName><forename type="first">Cpj</forename><surname>Maury</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lab Invest</title>
		<imprint>
			<biblScope unit="volume">72</biblScope>
			<biblScope unit="page" from="4" to="5" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">Contractile properties and susceptibility to exercise-induced damage of normal and mdx mouse tibialis anterior muscle</title>
		<author>
			<persName><forename type="first">P</forename><surname>Sacco</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Jones</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Jrt</forename><surname>Dick</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Vrbova</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Sci</title>
		<imprint>
			<biblScope unit="volume">82</biblScope>
			<biblScope unit="page" from="227" to="236" />
			<date type="published" when="1992">1992</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">Cellular infiltrates in human skeletal muscle: exercise induced damage as a model for inflammatory muscle disease</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Round</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Jones</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Cambridge</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurol Sci</title>
		<imprint>
			<biblScope unit="volume">82</biblScope>
			<biblScope unit="page" from="1" to="1" />
			<date type="published" when="1987">1987</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">Expression and function of heterotypic adhesion molecules during differentiation of human skeletal muscle in culture</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Beauchamp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Abraham</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Bou-Gharios</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">A</forename><surname>Partridge</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Olsen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Pathol</title>
		<imprint>
			<biblScope unit="volume">140</biblScope>
			<biblScope unit="page" from="387" to="401" />
			<date type="published" when="1992">1992</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">Constitutive and cytokineinduced production of interleukin-6 by human myoblasts</title>
		<author>
			<persName><forename type="first">E</forename><surname>Bartoccioni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Michaelis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Hohlfeld</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Immunol Lett</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="page" from="135" to="138" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">Acquisition of a lysosomal enzyme by myoblasts in tissue culture</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Beauchamp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">A</forename><surname>Partridge</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Olsen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Cell Physiol</title>
		<imprint>
			<biblScope unit="volume">144</biblScope>
			<biblScope unit="page" from="166" to="174" />
			<date type="published" when="1990">1990</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">T lymphocytes in aortic and coronary intimas: their potential role in atherogenesis</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">E</forename><surname>Emeson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Robertson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Pathol</title>
		<imprint>
			<biblScope unit="volume">130</biblScope>
			<biblScope unit="page" from="369" to="376" />
			<date type="published" when="1988">1988</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">T lymphocytes that infiltrate tumors and atherosclerotic plaques produce heparin-binding epidermal growth factor-like growth factor and basic fibroblast growth factor: a potential pathologic role</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">E</forename><surname>Peoples</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Blotnick</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Takahashi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Nat Acad Sci</title>
		<imprint>
			<biblScope unit="volume">92</biblScope>
			<biblScope unit="page" from="6547" to="6551" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main">The role of basic fibroblast growth factor in skeletal muscle regeneration</title>
		<author>
			<persName><forename type="first">M</forename><surname>Guthridge</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Wilson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Cowling</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Bertolini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">T</forename><surname>Hearn</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Growth Factors</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page" from="53" to="63" />
			<date type="published" when="1992">1992</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main">The time course of fibroblast growth factor expression in crush-injured skeletal muscles of SJIJJ and Balb/c mice</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Anderson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Mitchell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">K</forename><surname>Mcgeachie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Grounds</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Exp Cell Res</title>
		<imprint>
			<biblScope unit="volume">216</biblScope>
			<biblScope unit="page" from="325" to="334" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main">APP+ T lymphocytes selectively sorted to endomysial tubes in polymyositis displace NCAM-expressing muscle fibers</title>
		<author>
			<persName><forename type="first">W</forename><surname>Schubert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">L</forename><surname>Masters</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Beyreuther</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">EurJ Cell Biol</title>
		<imprint>
			<biblScope unit="volume">62</biblScope>
			<biblScope unit="page" from="333" to="342" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main">The biochemistry and cell biology of antigen processing and presentation</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">N</forename><surname>Germain</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">H</forename><surname>Margulies</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Annu Rev Immunol</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="403" to="450" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main">Map of the human MHC</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">D</forename><surname>Campbell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Trowsdale</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Immunol Today</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page" from="349" to="352" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main">HLA associations with inclusion body myositis</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Garlepp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Laing</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Zilko</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Ollier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">L</forename><surname>Mastaglia</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Exp Immunol</title>
		<imprint>
			<biblScope unit="volume">98</biblScope>
			<biblScope unit="page" from="40" to="45" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b52">
	<analytic>
		<title level="a" type="main">Rearrangement of 21-hydroxylase genes in disease-associated MHC supratypes</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Garlepp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">N</forename><surname>Wilton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Dawkins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">C</forename><surname>White</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Immunogenetics</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page" from="100" to="105" />
			<date type="published" when="1986">1986</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b53">
	<analytic>
		<title level="a" type="main">Susceptibility to IDDM is marked by MHC supratypes rather than individual alleles</title>
		<author>
			<persName><forename type="first">H</forename><surname>Kelly</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">J</forename><surname>Mccann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">H</forename><surname>Kay</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Immunogenetics</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="page" from="643" to="645" />
			<date type="published" when="1985">1985</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b54">
	<analytic>
		<title level="a" type="main">Disease associations with complotypes, supratypes and haplotypes</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Dawkins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">T</forename><surname>Christiansen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">H</forename><surname>Kay</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Immunol Rev</title>
		<imprint>
			<biblScope unit="volume">70</biblScope>
			<biblScope unit="page" from="5" to="22" />
			<date type="published" when="1983">1983</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b55">
	<analytic>
		<title level="a" type="main">HLA antigens and Bf allotypes in SLE: evidence for association being with specific haplotypes</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Black</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">I</forename><surname>Welsh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Fielder</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Tissue Antigens</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="page" from="115" to="120" />
			<date type="published" when="1982">1982</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b56">
	<analytic>
		<title level="a" type="main">Inclusion body myositis: clinical, morphological, physiological and laboratory findings in 18 cases</title>
		<author>
			<persName><forename type="first">C</forename><surname>Lindberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">I</forename><surname>Persson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Bjorkander</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Oldfors</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Acta Neurol Scand</title>
		<imprint>
			<biblScope unit="volume">89</biblScope>
			<biblScope unit="page" from="123" to="131" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b57">
	<analytic>
		<title level="a" type="main">Common variable immunodeficiency is associated with polymorphic markers in the human major histocompatibility complex</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">S</forename><surname>Howe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Akl</forename><surname>So</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Farrant</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Adb</forename><surname>Webster</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Exp Immunol</title>
		<imprint>
			<biblScope unit="volume">84</biblScope>
			<biblScope unit="page" from="387" to="390" />
			<date type="published" when="1991">1991</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b58">
	<analytic>
		<title level="a" type="main">Major histocompatibility complex class III genes and susceptibility to immunoglobulin A deficiency and common variable immunodeficiency</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Volanakis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z-B</forename><surname>Zhu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">M</forename><surname>Schaffer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Invest</title>
		<imprint>
			<biblScope unit="volume">89</biblScope>
			<biblScope unit="page" from="1914" to="1922" />
			<date type="published" when="1992">1992</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b59">
	<analytic>
		<title level="a" type="main">Differences in gene copy number carried by different MHC ancestral haplotypes</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">J</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Degli-Esposti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">J</forename><surname>Cobain</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Exp Med</title>
		<imprint>
			<biblScope unit="volume">171</biblScope>
			<biblScope unit="page" from="2101" to="2114" />
			<date type="published" when="1990">1990</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b60">
	<analytic>
		<title level="a" type="main">A new polymorphic and multicopy MHC gene family related to nonmammalian class I</title>
		<author>
			<persName><forename type="first">C</forename><surname>Leelayuwat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Degli-Esposti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">C</forename><surname>Townend</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">J</forename><surname>Abraham</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Dawkins</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Immunogenetics</title>
		<imprint>
			<biblScope unit="volume">40</biblScope>
			<biblScope unit="page" from="339" to="351" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b61">
	<analytic>
		<title level="a" type="main">Exons 16 and 17 of the amyloid precursor protein gene in familial inclusion body myopathy</title>
		<author>
			<persName><forename type="first">K</forename><surname>Sivakumar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Cervenikova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Dalakas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Neurol</title>
		<imprint>
			<biblScope unit="volume">38</biblScope>
			<biblScope unit="page" from="267" to="269" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b62">
	<analytic>
		<title level="a" type="main">Etiology and pathogenesis of prion diseases</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Dearmond</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">B</forename><surname>Prusiner</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Pathol</title>
		<imprint>
			<biblScope unit="volume">146</biblScope>
			<biblScope unit="page" from="785" to="811" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b63">
	<analytic>
		<title level="a" type="main">Association of apolipoprotein E allele e4 with late-onset familial and sporadic Alzheimer&apos;s disease</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Saunders</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">J</forename><surname>Strittmater</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Schmechel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">43</biblScope>
			<biblScope unit="page" from="1467" to="1472" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b64">
	<analytic>
		<title level="a" type="main">Apolipoprotein E: high affinity binding to ,BA amyloid and increased frequency of type 4 allele in familial Alzheimer&apos;s disease</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">J</forename><surname>Strittmater</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Saunders</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">E</forename><surname>Schmechel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci</title>
		<imprint>
			<biblScope unit="volume">90</biblScope>
			<biblScope unit="page" from="1977" to="1981" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b65">
	<analytic>
		<title level="a" type="main">Apolipoprotein E affects the rate of Alzheimer disease expression: 3-amyloid burden is a secondary consequence dependent on APOE genotype and duration of disease</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">D</forename><surname>Roses</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Neuropathol Exp Neurol</title>
		<imprint>
			<biblScope unit="volume">53</biblScope>
			<biblScope unit="page" from="429" to="437" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b66">
	<analytic>
		<title level="a" type="main">Apolipoprotein E type E4 allele frequency is not increased in patients with sporadic inclusion-body myositis</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">R</forename><surname>Harrington</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Anderson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">K</forename><surname>Chan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurosci Len</title>
		<imprint>
			<biblScope unit="volume">183</biblScope>
			<biblScope unit="page" from="35" to="38" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b67">
	<analytic>
		<title level="a" type="main">Apolipoprotein E E4 in inclusion body myositis</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Garlepp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Tabarias</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">M</forename><surname>Van Bockxmeer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Zilko</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Laing</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">L</forename><surname>Mastaglia</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Neurol</title>
		<imprint>
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
	<note>in press</note>
</biblStruct>

<biblStruct xml:id="b68">
	<analytic>
		<title level="a" type="main">Apolipoprotein E expression at neuromuscular junctions in mouse, rat and human skeletal muscle</title>
		<author>
			<persName><forename type="first">M</forename><surname>Akaaboune</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Villanova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">W</forename><surname>Festoff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Verdiere-Sahuque</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Hantai</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">FEBS Lett</title>
		<imprint>
			<biblScope unit="volume">351</biblScope>
			<biblScope unit="page" from="246" to="248" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b69">
	<analytic>
		<title level="a" type="main">Apolipoprotein E: cholesterol transport protein with expanding role in cell biology</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">W</forename><surname>Mahley</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">240</biblScope>
			<biblScope unit="page" from="622" to="630" />
			<date type="published" when="1988">1988</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b70">
	<analytic>
		<title level="a" type="main">Apolipoprotein E inhibition of proliferation of mitogen-activated T lymphocytes: production of interleukin-2 with reduced biological activity</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">E</forename><surname>Kelly</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Clay</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Mistry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Harmony</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell Immunol</title>
		<imprint>
			<biblScope unit="volume">159</biblScope>
			<biblScope unit="page" from="124" to="139" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b71">
	<analytic>
		<title level="a" type="main">Apolipoprotein E restricts interleukin-dependent T lymphocyte proliferation at the GlA/GIB boundary</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Mistry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Clay</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Kelly</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Steiner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Harmony</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell Immunol</title>
		<imprint>
			<biblScope unit="volume">160</biblScope>
			<biblScope unit="page" from="14" to="23" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b72">
	<analytic>
		<title level="a" type="main">Cloning of a gene bearing missense mutations in early-onset familial Alzheimer&apos;s disease</title>
		<author>
			<persName><forename type="first">R</forename><surname>Sherrington</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">I</forename><surname>Rogeav</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Liang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Levesque</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">375</biblScope>
			<biblScope unit="page" from="754" to="760" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b73">
	<analytic>
		<title level="a" type="main">APOE*4-associated Alzheimer&apos;s disease risk is modified by al-antichymotrypsin polymorphism</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">I</forename><surname>Kamboh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">K</forename><surname>Sanghera</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">E</forename><surname>Ferrell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">T</forename><surname>Dekosky</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature Genetics</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="486" to="488" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
